/PRNewswire/ Vivera Biosciences, a division of Vivera Pharmaceuticals dedicated to the research and development of innovative medical technologies and.
Shahriar SheikhBahaei, Ph.D.
Dr. SheikhBahaei’s interest in neuroscience stemmed from the usual combination of an aptitude for science and a medical problem (stuttering) that brought him into bioscience at a young age. Dr. SheikhBahaei received his bachelor’s degree from the University of California at Berkeley, where he worked with Dr. Bob Zucker on the regulation of neurotransmitter release and Dr. John Rubenstein (UC San Francisco) on development of GABAergic neurons in basal ganglia. Dr. SheikhBahaei completed his doctoral studies in Neuroscience (2017) jointly under NIMH/NINDS – University College London (UCL) Graduate Partnership Program where he worked with Drs. Jeffrey Smith (NINDS) and Alexander Gourine (UCL). His graduate studies were on how astrocytic networks control activities of respiratory motor circuits within the brainstem. After short postdoctoral research at NINDS, Dr. SheikhBahaei became an Independent Research Scholar in 2019. In collaboration with the lab
Credit: UCR School of Medicine.
RIVERSIDE, Calif. Astrocytes star-shaped cells in the brain that are actively involved in brain function may play an important role in stuttering, a study led by a University of California, Riverside, expert on stuttering has found. Our study suggests that treatment with the medication risperidone leads to increased activity of the striatum in persons who stutter, said Dr. Gerald A. Maguire, professor and chair of the Department of Psychiatry and Neuroscience at the UCR School of Medicine, who led the study. The mechanism of risperidone s action in stuttering, in part, appears to involve increased metabolism or activity of astrocytes in the striatum.